Macquarie Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-539
| Closed | -$35K | – | 2425 |
|
|
2022
Q3 | $35K | Sell |
539
-744
| -58% | -$48.3K | ﹤0.01% | 2036 |
|
|
2022
Q2 | $18K | Hold |
1,283
| – | – | ﹤0.01% | 2343 |
|
|
2022
Q1 | $25 | Hold |
1,283
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q4 | $21K | Hold |
1,283
| – | – | ﹤0.01% | 2387 |
|
|
2021
Q3 | $36K | Hold |
1,283
| – | – | ﹤0.01% | 2322 |
|
|
2021
Q2 | $38K | Hold |
1,283
| – | – | ﹤0.01% | 2220 |
|
|
2021
Q1 | $36K | Sell |
1,283
-353
| -22% | -$9.91K | ﹤0.01% | 2150 |
|
|
2020
Q4 | $46K | Hold |
1,636
| – | – | ﹤0.01% | 2058 |
|
|
2020
Q3 | $41K | Hold |
1,636
| – | – | ﹤0.01% | 2003 |
|
|
2020
Q2 | $40K | Buy |
+1,636
| New | +$40K | ﹤0.01% | 1984 |
|
|
2014
Q4 | – | Sell |
-6,000
| Closed | -$116K | – | 1617 |
|
|
2014
Q3 | $116K | Hold |
6,000
| – | – | ﹤0.01% | 1431 |
|
|
2014
Q2 | $204K | Buy |
6,000
+749
| +14% | +$25.5K | ﹤0.01% | 1439 |
|
|
2014
Q1 | $165K | Buy |
+5,251
| New | +$165K | ﹤0.01% | 1430 |
|